partnering

News

West Chester - Circa November 2020: AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

AstraZeneca partners Health2Sync on CKD digital support tool

Taiwan-based digital health firm Health2Sync has added another big pharma company to the roster of clients for its patient support platform.

News

Closeup of X-ray photography of human brain

AbbVie cuts Alzheimer's alliance with Alector in half

AbbVie is pulling out of its collaboration with Alector on the development of Alzheimer's disease candidate AL003, which aims to tackle the neurodegenerative disease by restoring reduced im

News

Astellas teams up with UK biotech Mogrify on hearing loss pr...

Cell therapy specialist Mogrify has struck a deal with Japanese drugmaker Astellas to look at ways to deploy regenerative medicine to treat hearing loss caused by factors such as chronic ex

News

Pfizer and Roivant launch autoimmune specialist Priovant

The latest start-up to emerge from the Roivant stable is named Priovant Therapeutics, and has been formed to develop a JAK1/TYK2 inhibitor originated by Pfizer as a treatment for autoimmune

News

Astellas pumps $90m into Sutro immuno-oncology alliance

Astellas has agreed a $1.36 billion partnership with US biotech Sutro Biopharma for a series of antibody-drug conjugates for cancer, focusing on applications in patients who don't respond t

News

Sanofi extends Health2Sync digital diabetes partnership to J...

Digital health company Health2Sync will work with Sanofi on digitising its range of insulin products in Japan, extending an earlier alliance in other markets.

AstraZeneca partners Health2Sync on CKD digital support tool

AbbVie cuts Alzheimer's alliance with Alector in half

Astellas teams up with UK biotech Mogrify on hearing loss pr...

Pfizer and Roivant launch autoimmune specialist Priovant

Astellas pumps $90m into Sutro immuno-oncology alliance

Sanofi extends Health2Sync digital diabetes partnership to J...

ADARx, Trex, and Retension take aim at IPOs

Discover a new era of healthcare panel engagement: Grounded ...

partnering

Editor's Picks